Your browser doesn't support javascript.
loading
Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.
Le, Dung T; Diaz, Luis A; Kim, Tae Won; Van Cutsem, Eric; Geva, Ravit; Jäger, Dirk; Hara, Hiroki; Burge, Matthew; O'Neil, Bert H; Kavan, Petr; Yoshino, Takayuki; Guimbaud, Rosine; Taniguchi, Hiroya; Élez, Elena; Al-Batran, Salah-Eddin; Boland, Patrick M; Cui, Yi; Leconte, Pierre; Marinello, Patricia; André, Thierry.
Afiliación
  • Le DT; Oncology, Sidney Kimmel Comprehensive Cancer Center at John Hopkins University, Baltimore, MD, USA. Electronic address: dle@jhmi.edu.
  • Diaz LA; Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Oncology, Asan Medical Center, Seoul, Republic of Korea.
  • Kim TW; Oncology, Asan Medical Center, Seoul, Republic of Korea; University of Ulsan, Ulsan, Republic of Korea.
  • Van Cutsem E; Digestive Oncology, University Hospitals Gasthuisberg, Leuven and KU Leuven, Leuven, Belgium.
  • Geva R; Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel.
  • Jäger D; Medical Oncology, University Medical Center Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany.
  • Hara H; Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Burge M; Cancer Care Services, Royal Brisbane Hospital, Brisbane, Queensland, Australia.
  • O'Neil BH; Oncology, Community North Cancer Center, Indianapolis, IN, USA.
  • Kavan P; Oncology, McGill University, Montreal, Quebec, Canada.
  • Yoshino T; Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Guimbaud R; Digestive Medical Oncology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Taniguchi H; Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Élez E; Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Al-Batran SE; Krankenhaus Nordwest, University Cancer Center (UCT), Frankfurt, Germany; Institute of Clinical Cancer Research (IKF), Frankfurt, Germany.
  • Boland PM; Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Cui Y; Biostatistician Oncology, MSD China, Beijing, China.
  • Leconte P; Medical Oncology, MSD France, Puteaux, France.
  • Marinello P; Medical Oncology, Merck & Co., Inc., Rahway, NJ, USA.
  • André T; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and SIRIC CURAMUS, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Paris, France; Medical Oncology Department, Hôpital Saint-Antoine, Paris, France.
Eur J Cancer ; 186: 185-195, 2023 06.
Article en En | MEDLINE | ID: mdl-37141828
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article